SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-358162
Filing Date
2015-10-29
Accepted
2015-10-29 17:00:30
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d85256d10q.htm 10-Q 462118
2 EX-31.1 d85256dex311.htm EX-31.1 9174
3 EX-31.2 d85256dex312.htm EX-31.2 9147
4 EX-32.1 d85256dex321.htm EX-32.1 3910
5 EX-32.2 d85256dex322.htm EX-32.2 3867
  Complete submission text file 0001193125-15-358162.txt   3274701

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT qlti-20150930.xml EX-101.INS 567694
7 XBRL TAXONOMY EXTENSION SCHEMA qlti-20150930.xsd EX-101.SCH 45247
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qlti-20150930_cal.xml EX-101.CAL 50210
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qlti-20150930_def.xml EX-101.DEF 151131
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE qlti-20150930_lab.xml EX-101.LAB 339566
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qlti-20150930_pre.xml EX-101.PRE 250514
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
QLT INC/BC (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17082 | Film No.: 151184421
SIC: 2834 Pharmaceutical Preparations